Title : Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial.

Pub. Date : 2007 Jun

PMID : 17548664






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial. Nicotine catechol-O-methyltransferase Homo sapiens
2 The genotype x treatment interaction effect at 12-week follow-up indicated a greater benefit of active nicotine replacement treatment compared with placebo on likelihood of abstinence in the COMT Met/Met genotype group (33% versus 12%), in comparison to the Met/Val + Val/Val group (22% versus 16%). Nicotine catechol-O-methyltransferase Homo sapiens
3 Our results indicate that COMT genotype may moderate the effect of active transdermal nicotine patch compared with placebo, with reduced relative benefit of nicotine replacement therapy in individuals with Met/Val or Val/Val genotype. Nicotine catechol-O-methyltransferase Homo sapiens